ETH Zurich spin-off Haelixa commercialises DNA markers that prove the origin and authenticity of materials along supply chains. It is raising EUR 2 million in pre-Series A funding for international expansion, team growth and anti-counterfeiting.
- Announced on
- Round
- Pre-Series A
- Amount
- EUR 2 M
- Location
- canton of Zurich
Investors
- Verve Ventures lead
- Zürcher Kantonalbank lead
- 212 NexT Fund
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic